In support of this, an increase in the histone methyltransferase, EZH2, in metastatic SCC compared to non‐metastatic tumours was associated with an impairment in innate immunity that enabled the escape of tumour cells from the immunosurveillance system to result in metastases.140. Here, EZH2 is linked to neoplasm.